Hypertension Clinical Trials

Showing 2081-2100 of 3,518 trials

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

NCT03726866

To evaluate pharmacokinetic properties and drug interactions between D326 and D337 co-administered groups, the CKD-828 alone and the total co-administered groups.

DyslipidemiasHypertension

Chong Kun Dang Pharmaceutical30 participantsStarted Aug 2018

Seoul, South Korea

COMPLETEDPhase 1

Pharmacokinetics and Safety Profile of CKD-333

NCT03659149

Compare the pharmacokinetic characteristics and safety between CKD-333 tablet and CKD-330, D086 combination

HypertensionDyslipidemias

Chong Kun Dang Pharmaceutical37 participantsStarted Aug 2018

Seoul, South Korea

UNKNOWNNA

SMART Technology to Promote Heart Health in Midlife Adults

NCT03724474

This study aims to increase weekly minutes of moderate-to-vigorous physical activity and improve sleep quality in a sample of mid-life adults between ages 50 and 64 years.

Physical ActivityPoor Quality SleepHypertension

University of Delaware60 participantsStarted Nov 2018

COMPLETED

Resistant Arterial Hypertension Cohort Study

NCT01083017

The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of two doses of the diuretic used - chlorthalidone), study two interventions in the group of patients that is non-compliant, and study environmental and genetic variables of individuals with resistant hypertension in a family design.

HypertensionEssential HypertensionResistant Hypertension

University Hospital, Geneva74 participantsStarted Apr 2011

Geneva, Switzerland • Lausanne, Switzerland • Lucerne, Switzerland

A Study to Investigate Drug-Drug Interaction Between D326, D337 and CKD-828 in Healthy Subjects

Pharmacokinetics and Safety Profile of CKD-333

SMART Technology to Promote Heart Health in Midlife Adults

Resistant Arterial Hypertension Cohort Study

Related Searches

Randomized Controlled Trial of Labetalol Versus Hydralazine for Severe Hypertension in Obstetric Patients.

Acute Response of Iloprost Inhalation Using the Breelib Nebulizer in Pulmonary Arterial Hypertension

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

The Effects of Pumpkin Seed Oil Supplementation on Cardiovascular Function in Postmenopausal Women.

PEEP Levels on Intraabdominal Pressure and Hemodynamics in Critically Ill Patients

Study to Confirm the Efficacy and Safety of Fixed-dose Combinations of Amlodipine and Candesartan

The CREATE Wellness Study

Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension

Sportcheck Follow-Up

Primary Technology Enhanced Care in Hypertension

Evaluating the Pharmacokinetic Interaction Between AD-2011 and AD-2012

OmniHeart Trial: Macronutrients and Cardiovascular Risk

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

PET/MRI in PAH Patients

Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension

A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)